MedTrace Logo

Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Hyperglycemia

NCT03258229 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-08-22

No results posted yet for this study

Summary

This study was conducted to investigate the effects of daily supplementation of Angelica gigas N. extract on improvement of Hyperglycemia .

Conditions

Interventions

DIETARY_SUPPLEMENT

Angelica gigas N. extract

capsules(2cap/d, 1,000mg/d) for 8 weeks.

DIETARY_SUPPLEMENT

Placebo

Placebo for 8 weeks

Sponsors & Collaborators

  • Chonbuk National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-09
Primary Completion
2017-12-07
Completion
2017-12-07

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03258229 on ClinicalTrials.gov